Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
RNA modifications in hematopoietic malignancies: a new research frontier.

Blood

Qing Y, Su R, Chen J.
PMID: 34157073
Blood. 2021 Aug 26;138(8):637-648. doi: 10.1182/blood.2019004263.

Protein-coding and noncoding RNAs can be decorated with a wealth of chemical modifications, and such modifications coordinately orchestrate gene expression during normal hematopoietic differentiation and development. Aberrant expression and/or dysfunction of the relevant RNA modification modulators/regulators ("writers," "erasers," and...

Cite
Qing Y, Su R, Chen J. RNA modifications in hematopoietic malignancies: a new research frontier. Blood. 2021;138(8):637-648doi: 10.1182/blood.2019004263.
Qing, Y., Su, R., & Chen, J. (2021). RNA modifications in hematopoietic malignancies: a new research frontier. Blood, 138(8), 637-648. https://doi.org/10.1182/blood.2019004263
Qing, Ying, et al. "RNA modifications in hematopoietic malignancies: a new research frontier." Blood vol. 138,8 (2021): 637-648. doi: https://doi.org/10.1182/blood.2019004263
Qing Y, Su R, Chen J. RNA modifications in hematopoietic malignancies: a new research frontier. Blood. 2021 Aug 26;138(8):637-648. doi: 10.1182/blood.2019004263. PMID: 34157073; PMCID: PMC8394902.
Copy Download .nbib Format: NLM
Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation.

Trends in genetics : TIG

Kan RL, Chen J, Sallam T.
PMID: 34294427
Trends Genet. 2021 Jul 19; doi: 10.1016/j.tig.2021.06.014. Epub 2021 Jul 19.

Epigenetic modifications occur on genomic DNA and histones to influence gene expression. More recently, the discovery that mRNA undergoes similar chemical modifications that powerfully impact transcript turnover and translation adds another layer of dynamic gene regulation. Central to precise...

Cite
Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2021;doi: 10.1016/j.tig.2021.06.014.
Kan, R. L., Chen, J., & Sallam, T. (2021). Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends in genetics : TIG, . https://doi.org/10.1016/j.tig.2021.06.014
Kan, Ryan L, et al. "Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation." Trends in genetics : TIG vol. (2021). doi: https://doi.org/10.1016/j.tig.2021.06.014
Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2021 Jul 19; doi: 10.1016/j.tig.2021.06.014. Epub 2021 Jul 19. PMID: 34294427.
Copy Download .nbib Format: NLM
Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.

Theranostics

Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D.
PMID: 34646384
Theranostics. 2021 Sep 21;11(19):9519-9537. doi: 10.7150/thno.65398. eCollection 2021.

B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with mixed-lineage leukemia gene rearrangement (MLL-r) is a poor-prognosis subtype for which additional therapeutic targets are urgently needed. Currently no multi-

Cite
Oliveira T, Zhang M, Joo EJ, et al. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics. 2021;11(19):9519-9537doi: 10.7150/thno.65398.
Oliveira, T., Zhang, M., Joo, E. J., Abdel-Azim, H., Chen, C. W., Yang, L., Chou, C. H., Qin, X., Chen, J., Alagesan, K., Almeida, A., Jacob, F., Packer, N. H., von Itzstein, M., Heisterkamp, N., & Kolarich, D. (2021). Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics, 11(19), 9519-9537. https://doi.org/10.7150/thno.65398
Oliveira, Tiago, et al. "Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia." Theranostics vol. 11,19 (2021): 9519-9537. doi: https://doi.org/10.7150/thno.65398
Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics. 2021 Sep 21;11(19):9519-9537. doi: 10.7150/thno.65398. eCollection 2021. PMID: 34646384; PMCID: PMC8490503.
Copy Download .nbib Format: NLM
Co-culture Systems of Drug-Treated Acute Myeloid Leukemia Cells and T Cells for In Vitro and In Vivo Study.

STAR protocols

Li Y, Su R, Chen J.
PMID: 32995754
STAR Protoc. 2020 Sep 18;1(2). doi: 10.1016/j.xpro.2020.100097. Epub 2020 Aug 28.

A combination of immunotherapy and chemotherapy strategies could strengthen antitumor effects. This protocol elucidates a robust method via co-culturing drug pre-treated acute myeloid leukemia cells with CD3

Cite
Li Y, Su R, Chen J. Co-culture Systems of Drug-Treated Acute Myeloid Leukemia Cells and T Cells for In Vitro and In Vivo Study. STAR Protoc. 2020;1(2)doi: 10.1016/j.xpro.2020.100097.
Li, Y., Su, R., & Chen, J. (2020). Co-culture Systems of Drug-Treated Acute Myeloid Leukemia Cells and T Cells for In Vitro and In Vivo Study. STAR protocols, 1(2), . https://doi.org/10.1016/j.xpro.2020.100097
Li, Yangchan, et al. "Co-culture Systems of Drug-Treated Acute Myeloid Leukemia Cells and T Cells for In Vitro and In Vivo Study." STAR protocols vol. 1,2 (2020). doi: https://doi.org/10.1016/j.xpro.2020.100097
Li Y, Su R, Chen J. Co-culture Systems of Drug-Treated Acute Myeloid Leukemia Cells and T Cells for In Vitro and In Vivo Study. STAR Protoc. 2020 Sep 18;1(2). doi: 10.1016/j.xpro.2020.100097. Epub 2020 Aug 28. PMID: 32995754; PMCID: PMC7521668.
Copy Download .nbib Format: NLM
Ten-eleven translocation protein 1 modulates medulloblastoma progression.

Genome biology

Kim H, Kang Y, Li Y, Chen L, Lin L, Johnson ND, Zhu D, Robinson MH, McSwain L, Barwick BG, Yuan X, Liao X, Zhao J, Zhang Z, Shu Q, Chen J, Allen EG, Kenney AM, Castellino RC, Van Meir EG, Conneely KN, Vertino PM, Jin P, Li J.
PMID: 33926529
Genome Biol. 2021 Apr 29;22(1):125. doi: 10.1186/s13059-021-02352-9.

BACKGROUND: Medulloblastoma (MB) is the most common malignant pediatric brain tumor that originates in the cerebellum and brainstem. Frequent somatic mutations and deregulated expression of epigenetic regulators in MB highlight the substantial role of epigenetic alterations. 5-hydroxymethylcytosine (5hmC) is...

Cite
Kim H, Kang Y, Li Y, et al. Ten-eleven translocation protein 1 modulates medulloblastoma progression. Genome Biol. 2021;22(1):125doi: 10.1186/s13059-021-02352-9.
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., Yuan, X., Liao, X., Zhao, J., Zhang, Z., Shu, Q., Chen, J., Allen, E. G., Kenney, A. M., Castellino, R. C., Van Meir, E. G., Conneely, K. N., Vertino, P. M., Jin, P., & Li, J. (2021). Ten-eleven translocation protein 1 modulates medulloblastoma progression. Genome biology, 22(1), 125. https://doi.org/10.1186/s13059-021-02352-9
Kim, Hyerim, et al. "Ten-eleven translocation protein 1 modulates medulloblastoma progression." Genome biology vol. 22,1 (2021): 125. doi: https://doi.org/10.1186/s13059-021-02352-9
Kim H, Kang Y, Li Y, Chen L, Lin L, Johnson ND, Zhu D, Robinson MH, McSwain L, Barwick BG, Yuan X, Liao X, Zhao J, Zhang Z, Shu Q, Chen J, Allen EG, Kenney AM, Castellino RC, Van Meir EG, Conneely KN, Vertino PM, Jin P, Li J. Ten-eleven translocation protein 1 modulates medulloblastoma progression. Genome Biol. 2021 Apr 29;22(1):125. doi: 10.1186/s13059-021-02352-9. PMID: 33926529; PMCID: PMC8082834.
Copy Download .nbib Format: NLM
Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.

Theranostics

Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D.
PMID: 34646384
Theranostics. 2021 Sep 21;11(19):9519-9537. doi: 10.7150/thno.65398. eCollection 2021.

B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with mixed-lineage leukemia gene rearrangement (MLL-r) is a poor-prognosis subtype for which additional therapeutic targets are urgently needed. Currently no multi-

Cite
Oliveira T, Zhang M, Joo EJ, et al. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics. 2021;11(19):9519-9537doi: 10.7150/thno.65398.
Oliveira, T., Zhang, M., Joo, E. J., Abdel-Azim, H., Chen, C. W., Yang, L., Chou, C. H., Qin, X., Chen, J., Alagesan, K., Almeida, A., Jacob, F., Packer, N. H., von Itzstein, M., Heisterkamp, N., & Kolarich, D. (2021). Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics, 11(19), 9519-9537. https://doi.org/10.7150/thno.65398
Oliveira, Tiago, et al. "Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia." Theranostics vol. 11,19 (2021): 9519-9537. doi: https://doi.org/10.7150/thno.65398
Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics. 2021 Sep 21;11(19):9519-9537. doi: 10.7150/thno.65398. eCollection 2021. PMID: 34646384; PMCID: PMC8490503.
Copy Download .nbib Format: NLM
Targeting FTO for cancer therapy and more.

Aging

Qing Y, Su R, Chen J.
PMID: 34382944
Aging (Albany NY). 2021 Aug 11;13(15):19080-19082. doi: 10.18632/aging.203404. Epub 2021 Aug 11.

No abstract available.

Cite
Qing Y, Su R, Chen J. Targeting FTO for cancer therapy and more. Aging (Albany NY). 2021;13(15):19080-19082doi: 10.18632/aging.203404.
Qing, Y., Su, R., & Chen, J. (2021). Targeting FTO for cancer therapy and more. Aging, 13(15), 19080-19082. https://doi.org/10.18632/aging.203404
Qing, Ying, et al. "Targeting FTO for cancer therapy and more." Aging vol. 13,15 (2021): 19080-19082. doi: https://doi.org/10.18632/aging.203404
Qing Y, Su R, Chen J. Targeting FTO for cancer therapy and more. Aging (Albany NY). 2021 Aug 11;13(15):19080-19082. doi: 10.18632/aging.203404. Epub 2021 Aug 11. PMID: 34382944; PMCID: PMC8386555.
Copy Download .nbib Format: NLM
Evaluation of glycolytic rates in human hematopoietic stem/progenitor cells after target gene depletion.

STAR protocols

Qing Y, Gao L, Han L, Su R, Chen J.
PMID: 34169295
STAR Protoc. 2021 Jun 11;2(2):100603. doi: 10.1016/j.xpro.2021.100603. eCollection 2021 Jun 18.

This protocol describes how to evaluate cellular metabolic state, including the glycolytic activity, in live CD34

Cite
Qing Y, Gao L, Han L, et al. Evaluation of glycolytic rates in human hematopoietic stem/progenitor cells after target gene depletion. STAR Protoc. 2021;2(2):100603doi: 10.1016/j.xpro.2021.100603.
Qing, Y., Gao, L., Han, L., Su, R., & Chen, J. (2021). Evaluation of glycolytic rates in human hematopoietic stem/progenitor cells after target gene depletion. STAR protocols, 2(2), 100603. https://doi.org/10.1016/j.xpro.2021.100603
Qing, Ying, et al. "Evaluation of glycolytic rates in human hematopoietic stem/progenitor cells after target gene depletion." STAR protocols vol. 2,2 (2021): 100603. doi: https://doi.org/10.1016/j.xpro.2021.100603
Qing Y, Gao L, Han L, Su R, Chen J. Evaluation of glycolytic rates in human hematopoietic stem/progenitor cells after target gene depletion. STAR Protoc. 2021 Jun 11;2(2):100603. doi: 10.1016/j.xpro.2021.100603. eCollection 2021 Jun 18. PMID: 34169295; PMCID: PMC8209740.
Copy Download .nbib Format: NLM
Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.

Theranostics

Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D.
PMID: 34646384
Theranostics. 2021 Sep 21;11(19):9519-9537. doi: 10.7150/thno.65398. eCollection 2021.

B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with mixed-lineage leukemia gene rearrangement (MLL-r) is a poor-prognosis subtype for which additional therapeutic targets are urgently needed. Currently no multi-

Cite
Oliveira T, Zhang M, Joo EJ, et al. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics. 2021;11(19):9519-9537doi: 10.7150/thno.65398.
Oliveira, T., Zhang, M., Joo, E. J., Abdel-Azim, H., Chen, C. W., Yang, L., Chou, C. H., Qin, X., Chen, J., Alagesan, K., Almeida, A., Jacob, F., Packer, N. H., von Itzstein, M., Heisterkamp, N., & Kolarich, D. (2021). Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics, 11(19), 9519-9537. https://doi.org/10.7150/thno.65398
Oliveira, Tiago, et al. "Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia." Theranostics vol. 11,19 (2021): 9519-9537. doi: https://doi.org/10.7150/thno.65398
Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics. 2021 Sep 21;11(19):9519-9537. doi: 10.7150/thno.65398. eCollection 2021. PMID: 34646384; PMCID: PMC8490503.
Copy Download .nbib Format: NLM
Ten-eleven translocation protein 1 modulates medulloblastoma progression.

Genome biology

Kim H, Kang Y, Li Y, Chen L, Lin L, Johnson ND, Zhu D, Robinson MH, McSwain L, Barwick BG, Yuan X, Liao X, Zhao J, Zhang Z, Shu Q, Chen J, Allen EG, Kenney AM, Castellino RC, Van Meir EG, Conneely KN, Vertino PM, Jin P, Li J.
PMID: 33926529
Genome Biol. 2021 Apr 29;22(1):125. doi: 10.1186/s13059-021-02352-9.

BACKGROUND: Medulloblastoma (MB) is the most common malignant pediatric brain tumor that originates in the cerebellum and brainstem. Frequent somatic mutations and deregulated expression of epigenetic regulators in MB highlight the substantial role of epigenetic alterations. 5-hydroxymethylcytosine (5hmC) is...

Cite
Kim H, Kang Y, Li Y, et al. Ten-eleven translocation protein 1 modulates medulloblastoma progression. Genome Biol. 2021;22(1):125doi: 10.1186/s13059-021-02352-9.
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., Yuan, X., Liao, X., Zhao, J., Zhang, Z., Shu, Q., Chen, J., Allen, E. G., Kenney, A. M., Castellino, R. C., Van Meir, E. G., Conneely, K. N., Vertino, P. M., Jin, P., & Li, J. (2021). Ten-eleven translocation protein 1 modulates medulloblastoma progression. Genome biology, 22(1), 125. https://doi.org/10.1186/s13059-021-02352-9
Kim, Hyerim, et al. "Ten-eleven translocation protein 1 modulates medulloblastoma progression." Genome biology vol. 22,1 (2021): 125. doi: https://doi.org/10.1186/s13059-021-02352-9
Kim H, Kang Y, Li Y, Chen L, Lin L, Johnson ND, Zhu D, Robinson MH, McSwain L, Barwick BG, Yuan X, Liao X, Zhao J, Zhang Z, Shu Q, Chen J, Allen EG, Kenney AM, Castellino RC, Van Meir EG, Conneely KN, Vertino PM, Jin P, Li J. Ten-eleven translocation protein 1 modulates medulloblastoma progression. Genome Biol. 2021 Apr 29;22(1):125. doi: 10.1186/s13059-021-02352-9. PMID: 33926529; PMCID: PMC8082834.
Copy Download .nbib Format: NLM
Author Correction: Recognition of RNA N.

Nature cell biology

Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, Zhao BS, Mesquita A, Liu C, Yuan CL, Hu YC, Hüttelmaier S, Skibbe JR, Su R, Deng X, Dong L, Sun M, Li C, Nachtergaele S, Wang Y, Hu C, Ferchen K, Greis KD, Jiang X, Wei M, Qu L, Guan JL, He C, Yang J, Chen J.
PMID: 29880862
Nat Cell Biol. 2018 Sep;20(9):1098. doi: 10.1038/s41556-018-0102-7.

In the version of this Article originally published, the authors incorrectly listed an accession code as GES90642. The correct code is GSE90642 . This has now been amended in all online versions of the Article.

Cite
Huang H, Weng H, Sun W, et al. Author Correction: Recognition of RNA N. Nat Cell Biol. 2018;20(9):1098doi: 10.1038/s41556-018-0102-7.
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., Hu, Y. C., Hüttelmaier, S., Skibbe, J. R., Su, R., Deng, X., Dong, L., Sun, M., Li, C., Nachtergaele, S., Wang, Y., Hu, C., Ferchen, K., Greis, K. D., Jiang, X., Wei, M., Qu, L., Guan, J. L., He, C., Yang, J., & Chen, J. (2018). Author Correction: Recognition of RNA N. Nature cell biology, 20(9), 1098. https://doi.org/10.1038/s41556-018-0102-7
Huang, Huilin, et al. "Author Correction: Recognition of RNA N." Nature cell biology vol. 20,9 (2018): 1098. doi: https://doi.org/10.1038/s41556-018-0102-7
Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, Zhao BS, Mesquita A, Liu C, Yuan CL, Hu YC, Hüttelmaier S, Skibbe JR, Su R, Deng X, Dong L, Sun M, Li C, Nachtergaele S, Wang Y, Hu C, Ferchen K, Greis KD, Jiang X, Wei M, Qu L, Guan JL, He C, Yang J, Chen J. Author Correction: Recognition of RNA N. Nat Cell Biol. 2018 Sep;20(9):1098. doi: 10.1038/s41556-018-0102-7. PMID: 29880862.
Copy Download .nbib Format: NLM
Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation.

Trends in genetics : TIG

Kan RL, Chen J, Sallam T.
PMID: 34294427
Trends Genet. 2022 Feb;38(2):182-193. doi: 10.1016/j.tig.2021.06.014. Epub 2021 Jul 19.

Epigenetic modifications occur on genomic DNA and histones to influence gene expression. More recently, the discovery that mRNA undergoes similar chemical modifications that powerfully impact transcript turnover and translation adds another layer of dynamic gene regulation. Central to precise...

Cite
Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2021;38(2):182-193doi: 10.1016/j.tig.2021.06.014.
Kan, R. L., Chen, J., & Sallam, T. (2022). Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends in genetics : TIG, 38(2), 182-193. https://doi.org/10.1016/j.tig.2021.06.014
Kan, Ryan L, et al. "Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation." Trends in genetics : TIG vol. 38,2 (2022): 182-193. doi: https://doi.org/10.1016/j.tig.2021.06.014
Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2022 Feb;38(2):182-193. doi: 10.1016/j.tig.2021.06.014. Epub 2021 Jul 19. PMID: 34294427.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries